National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1
Joel M. Gelfand, April W. Armstrong, Stacie Bell, George L. Anesi, Andrew Blauvelt, Cassandra Calabrese, Erica D. Dommasch, Steven R. Feldman, Dafna D. Gladman, Leon Kircik, Mark Lebwohl, Vincent Lo Re, George M. Martin, Joseph F. Merola, José U. Scher, Sergio Schwartzman, James R. Treat, Abby S. Van Voorhees, Christoph T. Ellebrecht, Justine Fenner, Anthony J. Ocon, Maha N. Syed, Erica J. Weinstein, Jessica Smith, George Gondo, Sue Heydon, Samantha Koons, Christopher T. Ritchlin
Topics & Concepts
MedicineTask forcePsoriasisPandemicCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Foundation (evidence)DiseaseDermatologyVirologyPathologyInfectious disease (medical specialty)OutbreakPolitical sciencePublic administrationArchaeologyHistoryPsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsCOVID-19 and healthcare impacts